Botulinum Toxin Type A (BOTOX) Treatment of Masseter Muscle Hypertrophy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Hypertrophy
- Focus Therapeutic Use
- Sponsors Allergan
- 18 Jan 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
- 18 Jan 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Mar 2017.
- 18 Jan 2017 Status changed from recruiting to active, no longer recruiting.